• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Abiomed

These medtech stocks performed the best in 2020

January 15, 2021 By Sean Whooley Leave a Comment

While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while […]

Filed Under: 510(k), Big Data, Business/Financial News, Cardiac Implants, Cardiovascular, Diabetes, Diagnostics, Drug-Device Combinations, Electronic Medical Records (EMR), Featured, Food & Drug Administration (FDA), Funding Roundup, Genomics/Molecular Diagnostics, Health Technology, MassDevice Earnings Roundup, Mergers & Acquisitions, Orthopedics, Regulatory/Compliance, Replacement Heart Valves, Research & Development, Respiratory, Robotics, Software / IT, Structural Heart, Surgical, Wall Street Beat Tagged With: Abbott, Abiomed, coronavirus, COVID-19, Dexcom, Edwards Lifesciences, Hologic, Intuitive Surgical, iRhythm Technologies Inc., Masimo, ResMed, ResMed Inc., Stryker

First patients treated with Abiomed ECMO tech

December 22, 2020 By Sean Whooley

Abiomed (NSDQ:ABMD) announced that it treated the first two patients with its Abiomed Breethe OXY-1 compact cardiopulmonary bypass system. Danvers, Mass.-based Abiomed’s extracorporeal membrane oxygenation (ECMO) technology pumps, oxygenates and removes carbon dioxide from blood for patients whose lungs can’t provide sufficient end-organ oxygenation, according to a news release. Breethe OXY-1 is designed to help oxygenate […]

Filed Under: Blood Management, Cardiovascular, Featured, Respiratory, Structural Heart Tagged With: Abiomed

How did medtech companies score on environmental stewardship list?

December 8, 2020 By Nancy Crotti

Medical Design & Outsourcing recently rated the world’s largest medical device companies — the Big 100 — for their sales numbers and R&D spend. Now we can share how some of them scored on an environmental nonprofit’s annual list of companies ranked for their actions on climate change. Not-for-profit organization CDP (Stockholm, Sweden) runs a global disclosure system for […]

Filed Under: Business/Financial News, Featured Tagged With: 3m, Abbott, Abiomed, Align Technology, Baxter, Bayer, becton dickinson, Boston Scientific, Canon, Cardinal Health, Carl Zeiss Meditec, CDP, danaher, Edwards Lifesciences, elkemsilicones, emerson, Fujifilm, Henry Schein Medical, Hologic, Intuitive Surgical, Johnson & Johnson, Kyocera, Medtronic, Olympus, PerkinElmer Inc., Qualcomm, ResMed, Robert Bosch North America, royalphilips, stericycle, Steris Corp., Stryker, TE Connectivity, Terumo, Tessy Plastics, Thermo Fisher Scientific, Toray Industries, Varian Medical Systems, Zimmer Biomet

Study: ECMO ‘significantly’ improves heart attack patients’ survival

November 13, 2020 By Sean Whooley

The National Institutes of Health (NIH) is touting a study that found the use of life support improved survival in certain cardiac arrest patients. Published in The Lancet, the study, known as the Advanced Reperfusion Strategies for Refractory Cardiac Arrest (ARREST) trial, used the life support machine called extracorporeal membrane oxygenation ECMO to replicate the […]

Filed Under: Cardiovascular, Clinical Trials, Featured Tagged With: Abiomed, and Blood Institute NHLBI, coronavirus, COVID-19, LivaNova, Medtronic, National Institutes of Health (NIH)

Abiomed slides despite beating The Street in Q2

October 29, 2020 By Sean Whooley

Abiomed (NSDQ:ABMD) shares took a hit today on second-quarter results that beat the consensus forecast. The Danvers, Mass.-based company posted profits of $62.2 million, or $1.36 per share, on sales of $209.8 million for the three months ended Sept. 30, 2020, nearly quadrupling its bottom line on sales growth of 2.3%. Adjusted to exclude one-time items, […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, MassDevice Earnings Roundup, Structural Heart, Wall Street Beat Tagged With: Abiomed

FDA clears Abiomed compact cardiopulmonary bypass system

October 26, 2020 By Chris Newmarker

Abiomed (NSDQ:ABMD) announced today that FDA has granted a 510(k) clearance for its Breethe OXY-1 system — which among other things could help treat people with severe cases of COVID-19. The Abiomed Breethe OXY-1 system is an all-in-one, compact cardiopulmonary bypass system. It provides cardiopulmonary bypass support for people whose lungs are no longer able to […]

Filed Under: 510(k), Cardiovascular, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: Abiomed, coronavirus, COVID-19

Abiomed touts latest Impella trial results

October 15, 2020 By Nancy Crotti

Abiomed (NSDQ:ABMD) today announced interim results of a study that found high-risk patients had better outcomes after implantation with its Impella CP heart pump. Data from the PROTECT III FDA post-approval study of Impella 2.5 and Impella CP in high-risk percutaneous coronary intervention (PCI) patients showed reduced rates of MACCE — a composite of death, stroke, […]

Filed Under: Cardiovascular, Clinical Trials, Featured, Food & Drug Administration (FDA), Implants Tagged With: Abiomed, FDA, TCT 2020

CMS rate cuts for Abiomed Impella not as bad as expected

September 3, 2020 By Chris Newmarker

CMS will pay 11% less for the tiny Impella heart pump made by Abiomed (NSDQ:ABMD) during the upcoming federal fiscal year — but the reduction is better than the 24% cut originally proposed. For the federal fiscal year ended Sept. 30, 2021, the rate for uni-ventricular Impella percutaneous insertion will be $71,950, down from the previous […]

Filed Under: Business/Financial News, Cardiovascular Tagged With: Abiomed, Centers for Medicare and Medicaid Services (CMS)

Medtech stocks help boost S&P rally

August 18, 2020 By Sean Whooley

Medtech stocks helped the S&P 500 Index reach record highs today amid a bounceback from the lows of the COVID-19 pandemic. Reuters reported that medtech played its part in the record turn of the market, with Abiomed (NSDQ:ABMD), Regeneron Pharmaceuticals (NSDQ:REGN) and West Pharmaceutical Services (NYSE:WST), all of which are involved in developing COVID-19 therapeutics, all rising more […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: Abiomed, coronavirus, COVID-19, MedTech 100 Index, Regeneron, S&P, West Pharmaceutical Services Inc.

MedTech 100 roundup: Another high as stocks tick up

August 10, 2020 By Sean Whooley

For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: 3m, Abiomed, Acutus Medical, becton dickinson, Cardinal Health, CHF Solutions Inc., coronavirus, COVID-19, DeviceTalks Weekly, Dow Jones, Gilead Sciences, Insulet, Johnson and Johnson, Livongo, MedTech 100 Index, Orthofix, Pfizer, ResMed Inc., S&P, Siemens Healthineers, Teladoc, TransEnterix, Varian Medical Systems

Abiomed shares slide on Street-beating Q1 results

August 6, 2020 By Danielle Kirsh

Abiomed (NSDQ:ABMD) posted first-quarter results today that beat the consensus on Wall Street. The Danvers, Mass.-based company reported profits of $44.6 million, or 98¢ per share, on sales of $164.9 million for the three months ended June 30, for a bottom-line loss of -95% sales loss of -20.6% compared with Q1 2019. Adjusted to exclude one […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Abiomed

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 27
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS